Work

RT-PCR analysis of EGFR extracellular domain mutations in the remaining CBRC NB tumors from A Novel EGFR Extracellular Domain Mutant, EGFRΔ768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma

Year: 2023

Type: other

Abstract: S1. All PCR products were confirmed to be either EGFRÎ"768 or EGFRvIII by bidirectional sequencing. Gel purified EGFRvIII and EGFRÎ"768 cDNA were positive controls. H2O was negative control.

DOI: 10.1158/1541-7786.22511473

Authors: James Keller, Anjaruwee S. Nimnual, Mathew S. Varghese, Kristen A. VanHeyst, Michael J. Hayman, Edward L. Chan

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362482989

Cites:

Cited by:

Related to: 10